Page 7 - Brain Bleeding News Today

A new cost analysis taking into account spending on ancillary health services suggests that prior cost analyses underestimated the anticipated costs of aducanumab.

Cannabis use was linked to significantly increased risk of delayed cerebral hemorrhage in patients with aneurysmal SAH, potentially due to vasospasm, new research suggests.

When considering the choice of oral anticoagulant in patients with atrial fibrillation, apixaban appears to be preferable to rivaroxaban, another new study suggests.

Patients who experience stroke -- hemorrhagic or otherwise -- have a "very high" risk of epilepsy one year later, new research shows.

Consider repeat head CT scans for trauma patients who are taking any anticoagulants or antiplatelet medications concurrently with aspirin, researchers say.

A Waukesha mother is rallying support for a young dancer injured in the city's Christmas parade.

A recent systematic review provides more definitive evidence of a cancer-stroke link.

In stroke patients carrying CYP2C19 loss-of-function alleles that impede metabolism of clopidogrel, ticagrelor was more effective than clopidogrel at reducing recurrent stroke in the CHANCE-2 trial.

Calculating the estimated glucose disposal rate as a proxy for the level of insulin resistance may be useful way to determine if someone with type 2 diabetes is at risk for having a first stroke, Swedish researchers have found.

Draft recommendations suggest those aged 40-59 at low bleeding but high CVD risk may consider aspirin for prevention, but advise against it in those 60 and older, or for colorectal cancer prevention.